Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty

PROTAC EZH2 Degrader-1

😃Good
Catalog No. T74602Cas No. 2641601-67-2

PROTAC EZH2 Degrader-1 (Compound 150d) is a potent PROTAC molecule that effectively suppresses EZH2 methyltransferase activity, with a half-maximal IC50 of 2.7 nM. EZH2 is a histone methyltransferase crucial to tumorigenesis and cancer progression, and PROTAC EZH2 Degrader-1 represents an important chemical tool for probing its therapeutic relevance.

PROTAC EZH2 Degrader-1

PROTAC EZH2 Degrader-1

😃Good
Catalog No. T74602Cas No. 2641601-67-2
PROTAC EZH2 Degrader-1 (Compound 150d) is a potent PROTAC molecule that effectively suppresses EZH2 methyltransferase activity, with a half-maximal IC50 of 2.7 nM. EZH2 is a histone methyltransferase crucial to tumorigenesis and cancer progression, and PROTAC EZH2 Degrader-1 represents an important chemical tool for probing its therapeutic relevance.
Pack SizePriceUSA WarehouseGlobal WarehouseQuantity
1 mg$2157-10 days7-10 days
5 mg$6457-10 days7-10 days
10 mg$9757-10 days7-10 days
Add to Cart
Add to Quotation
In Stock Estimated shipping dateUSA Warehouse[1-2 days] Global Warehouse[5-7 days]
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.
Questions
TargetMol
View More

Batch Information

Select Batch
Appearance:Solid
Color:White
Contact us for more batch information

Resource Download

Product Introduction

Bioactivity
Description
PROTAC EZH2 Degrader-1 (Compound 150d) is a potent PROTAC molecule that effectively suppresses EZH2 methyltransferase activity, with a half-maximal IC50 of 2.7 nM. EZH2 is a histone methyltransferase crucial to tumorigenesis and cancer progression, and PROTAC EZH2 Degrader-1 represents an important chemical tool for probing its therapeutic relevance.
Targets&IC50
EZH2:2.7 nM
In vitro
Methods: H128 cells were pretreated with PROTAC EZH2 Degrader-1 (2 nM), followed by treatment with carboplatin, etoposide, and teniposide for 72 hours. Cell viability was assessed using the CCK8 assay.
Results: PROTAC EZH2 Degrader-1 significantly reduced the IC50 values of carboplatin, etoposide, and teniposide in H128-LM cells.[2]
In vivo
Methods: PROTAC EZH2 Degrader-1 (0.5 mg/kg, once weekly for a total of 3 doses) was administered intraperitoneally to H128-LM xenograft mice to evaluate tumor growth.
Results: The combination of PROTAC EZH2 degrader-1 with carboplatin, etoposide, and teniposide significantly inhibited the growth of H128-LM tumors, demonstrating superior efficacy compared to chemotherapy drugs used alone.[2]
Chemical Properties
Molecular Weight942.15
FormulaC54H67N7O8
Cas No.2641601-67-2
SmilesO=C(NCC=1C(=O)NC(=CC1C)C)C2=CC(=CC(=C2C)N(CC)C3CCOCC3)C4=CC=C(C=C4)CN5CCN(CC5)CCCCCCCOC6=CC=CC=7C(=O)N(C(=O)C67)C8C(=O)NC(=O)CC8
Storage & Solubility Information
Storagekeep away from moisture,store at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.
Solubility Information
DMSO: 80 mg/mL (84.91 mM), Sonication is recommended.
Solution Preparation Table
DMSO
1mg5mg10mg50mg
1 mM1.0614 mL5.3070 mL10.6140 mL53.0701 mL
5 mM0.2123 mL1.0614 mL2.1228 mL10.6140 mL
10 mM0.1061 mL0.5307 mL1.0614 mL5.3070 mL
20 mM0.0531 mL0.2654 mL0.5307 mL2.6535 mL
50 mM0.0212 mL0.1061 mL0.2123 mL1.0614 mL

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the stock solution preparation method and in vivo formula preparation method:
TargetMol | Animal experiments For example, if the intended dosage is 10 mg/kg for animals weighing 20 g , with a dosing volume of 100 μL per animal, TargetMol | Animal experiments and a total of 10 animals are to be administered, using a formulation of TargetMol | reagent 10% DMSO+ 40% PEG300+ 5% Tween 80+ 45% Saline/PBS/ddH2O , the resulting working solution concentration would be 2 mg/mL.
Stock Solution Preparation:

Dissolve 2 mg of the compound in 100 μL DMSOTargetMol | reagent to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.

Preparation of the In Vivo Formulation:

1) Add 100 μL of the DMSOTargetMol | reagent stock solution to 400 μL PEG300TargetMol | reagent and mix thoroughly until the solution becomes clear.

2) Add 50 μL Tween 80 and mix well until fully clarified.

3) Add 450 μL Saline,PBS or ddH2OTargetMol | reagent and mix thoroughly until a homogeneous solution is obtained.

This example is provided solely to demonstrate the use of the In Vivo Formulation Calculator and does not constitute a recommended formulation for any specific compound. Please select an appropriate dissolution and formulation strategy based on your experimental model and route of administration.
All co-solvents required for this protocol, includingDMSO, PEG300/PEG400, Tween 80, SBE-β-CD, and Corn oil, are available for purchase on the TargetMol website.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
% Tween 80
% Saline/PBS/ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc
Related Tags: buy PROTAC EZH2 Degrader-1 | purchase PROTAC EZH2 Degrader-1 | PROTAC EZH2 Degrader-1 cost | order PROTAC EZH2 Degrader-1 | PROTAC EZH2 Degrader-1 chemical structure | PROTAC EZH2 Degrader-1 in vivo | PROTAC EZH2 Degrader-1 in vitro | PROTAC EZH2 Degrader-1 formula | PROTAC EZH2 Degrader-1 molecular weight